A very early stage biotech opportunity with links to big pharma. We are seeing small scattered call buying today.
Black Friday Sales are expected to be dominated by online shopping with overall sales increasing by 5% from 2019. Is this a low estimate?
Biotech and Solar ETFs breakout, while gold broke down this week.
We are following up on a recent IPO idea published on our telegram channel. This Medtech company looks towards a post COVID expansion in Europe and Asia.
This early stage media company sells at 20% percent discounted valuation to Netflix. It has double the revenue growth, higher margins and its service is only priced at $15/year!
The move from Growth stocks to Value names has been quick and decisive. We look at a big name tech stock to take advantage of a rotation back into growth.
Politics removed, markets continue higher on COVID vaccine news, Congressional agreement around stimulus packages, and hopes of central bank support of positive, but low, interest rates.
The mining sector shows activity as a value play. Tech stocks are not all holding up.